Percutaneous Coronary Intervention Market - Trends Forecast Till 2028

Percutaneous Coronary Intervention Market, By Type (Balloon Angioplasty, Angioplasty With Stent, Laser Angioplasty, Rotational Atherectomy, CTO (Chronic Total Occlusions), Coronary Guidewires, Coronary Stents, Ptca Catheters, Embolic Protection Devices (EPDs)), Techniques (Advanced Imaging, Fractional Flow Reserve (FRR), Radial Artery Access), Disease (Angina, Myocardial Infraction (MI), Multivessel Coronary Artery Disease (CAD)), End User (Hospital, Cardiac Centers, Ambulatory Surgical Centers, Specialty Centers, Cath Labs, Others), Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: September, 2020

Base Year Estimate: 2019

Report ID: D-HC-PCIM-47

Format:  

Number of Pages: 292

Domain: Healthcare

Percutaneous Coronary Intervention Market – Trends Forecast Till 2028

The global percutaneous coronary intervention market is anticipated to reach USD 16.7 billion by 2020 growing at a CAGR of 7.2% during the forecasting period, 2020-2028. Percutaneous Coronary Intervention is a non-invasive procedure that is used for treating the narrowing arteries of the heart in coronary artery diseases including angina, acute myocardial infarction, and multivessel coronary artery disease (CAD). Factors such as rising risk factors associated with heart diseases such as obesity, smoking, and substance abuse, fatty foods, etc and rising geriatric and pediatric population are some of the major drivers for the market of percutaneous coronary intervention

Percutaneous Coronary Intervention Market – Trends Forecast Till 2028

The global percutaneous coronary intervention market is segmented into type, technique, disease, end-user, and geography.

The type segment is segmented into Balloon Angioplasty, Angioplasty with Stent, Laser Angioplasty, Rotational Atherectomy, CTO (Chronic Total Occlusions), Coronary Guidewires, Coronary Stents, PTCA Catheters, Embolic Protection Devices (EPDs). Balloon Angioplasty segment is further segmented into Aorta, Iliac Artery, Femoral Artery, Popliteal Artery, Tibial and Peroneal Arteries. Angioplasty with Stent is further segmented into Dual Therapy Stent, Bioresorbable Vascular Scaffold, Bio-Engineered Stent, Drug-Eluting Stent, and bare-metal stent. The Rotational Atherectomy segment is further segmented into Low-Speed Rotational Atherectomy, High-Speed Rotational Atherectomy. CTO (Chronic Total Occlusions) segment is further segmented into Retrograde Technique, Anterograde Technique with Wire Scaling, Anterograde Dissection, and Reentry Technique and Others.

Techniques are segmented into Advanced Imaging, Fractional Flow Reserve (FRR), and Radial Artery Access

The disease is segmented into Angina, Myocardial Infraction (MI), Multivessel Coronary Artery Disease (CAD). Angina is further segmented into Unstable Angina, Stable Angina. Myocardial Infraction is further segmented into Acute Non-ST Elevation Myocardial Infarction, Acute ST-Elevation Myocardial Infarction. Multivessel Coronary Artery Disease is further segmented into Obstructive Coronary Artery Disease and Spontaneous Coronary Artery Dissection (SCAD).

End-User is segmented into Hospital, Cardiac Centers, Ambulatory Surgical Centers, Specialty Centers, Cath Labs, and Others

Geographically, the global percutaneous coronary intervention market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions

North America region is the largest contributor to the percutaneous coronary intervention market in the forecast period 2020-2028.

Key players in global percutaneous coronary intervention market Abbott, Asahi Intecc Company Limited, B. Braun Melsungen AG, Biosensors International Group, Ltd., Biotronik, Boston Scientific Corporation, C. R. Bard, Inc., Comed B.V., Cook, Cordis, Medtronic, Merit Medical System, Terumo Corporation, Philips Healthcare among others

The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:

  • In 2019, Abbott has announced to acquire Cephea Valve Technologies Inc., which is engaged in developing a minimally invasive mitral valve replacement system. 
  • In 2018, Medtronic has announced the launch of the first 2.0 mm Drug-Eluting Stent in the United States designed to treat patients with small vessels

Available Customizations

In addition to the market data for the percutaneous coronary intervention market, Delvens. offers client-centric reports and customized according to the company’s specific demand and requirement.

Research Methodology

Secondary Research

This research method involved the usage of extensive secondary sources (such as directories and databases)—Hoovers, Avention, annual reports, investor presentation, conferences like Jefferies conference)—to identify and collect information useful for this study of the percutaneous coronary intervention market. The purpose of secondary research is to identify and collection of extensive, technical, market-oriented, and commercial studies of the global percutaneous coronary intervention market. Through secondary research, the market is classified and segmented as per industry trends, developments, regional markets, products, and technology developments. 

Primary Research

The primary sources mainly included several industry experts from the core and related industries and suppliers, manufacturers, distributors, alliances, and organizations related to all segments of this industry’s supply chain. In-depth interviews were conducted with various primary respondents—including key industry participants, subject matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts—to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. The following figure depicts the market research methodology used in drafting this report on the percutaneous coronary intervention market.

The primary respondent breakdown is provided below:

Percutaneous Coronary Intervention Market – Trends Forecast Till 2028

Market Sizing

Top-down and bottom approaches were used to derive the market estimate and validate the total revenue of the percutaneous coronary intervention market. This approach has also been used to derive the market for segmentation and sub-segmentation. 

Data Validation

Impact analysis has been conducted for deriving the market size. After collecting the in-depth quantitative and qualitative data we contact primary respondents in order to gain a 98.8% of confidence level on our data.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants 

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors
  • Gain authentic and granular data access for the percutaneous coronary intervention market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Features

Description

Market Revenue In 2020

USD 16.7 billion

Growth Rate

CAGR of 7.9% during the forecasting period, 2020-2028

Historical Data

2017-2018

Forecast Years

2020-2028

Base Year 

2019

Units Considered

Revenue in USD billion and CAGR from 2020 to 2028

Report Segmentation

Type, Technique, Disease, End-User, and Geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and the Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Abbott, Asahi Intecc Company Limited, B. Braun Melsungen AG, Biosensors International Group, Ltd., Biotronik, Boston Scientific Corporation, C. R. Bard, Inc., Comed B.V., Cook, Cordis, Medtronic, Merit Medical System, Terumo Corporation, Philips Healthcare among others

Available Customization 

In addition to the market data for the percutaneous coronary intervention market, Delvens. offers client-centric reports and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.